Formycon AG
Formycon AG, a leading biopharmaceutical company headquartered in Germany, is renowned for its expertise in the development of biosimilars. Founded in 2002, the company has established a strong presence in Europe and beyond, focusing on innovative therapies that enhance patient care. With a commitment to quality and efficacy, Formycon AG offers a range of biosimilar products that stand out for their rigorous development processes and regulatory compliance. The company has achieved significant milestones, including successful partnerships and product launches that underscore its position in the competitive biopharmaceutical landscape. Recognised for its scientific excellence, Formycon AG continues to drive advancements in the industry, making substantial contributions to the accessibility of biologic treatments for patients worldwide.
DitchCarbon Score
How does Formycon AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Formycon AG's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Formycon AG's reported carbon emissions
Formycon AG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or commitments to the Science Based Targets initiative (SBTi). While there are no specific climate pledges or initiatives detailed, Formycon AG is actively engaged in sustainability practices, as evidenced by their participation in the Carbon Disclosure Project (CDP). However, without concrete emissions data or defined reduction targets, it is challenging to assess their overall climate impact or commitments comprehensively. As the company continues to develop its sustainability strategy, stakeholders may look forward to future disclosures that could provide insights into their carbon footprint and climate action plans.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Formycon AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
